menu
    • menu
    [{"orgOrder":0,"company":"Chengdu Maxvax Biotechnology","sponsor":"Henan Center for Disease Control and Prevention | Hunan Provincial Center for Disease Control and Prevention | Hubei Provincial Center for Disease Control and Prevention | Shaanxi Provincial Center for Disease Control and Prevention | Guangdong Center for","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"CHINA","productType":"Vaccine","year":"2025","type":"Inapplicable","leadProduct":"Recombinant Respiratory Syncytial Virus Vaccine","moa":"Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Phase III","graph3":"Chengdu Maxvax Biotechnology","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Injection","sponsorNew":"Chengdu Maxvax Biotechnology \/ Henan Center for Disease Control and Prevention | Hunan Provincial Center for Disease Control and Prevention | Hubei Provincial Center for Disease Control and Prevention | Shaanxi Provincial Center for Disease Control and Prevention | Guangdong Center for","highestDevelopmentStatusID":"10","companyTruncated":"Chengdu Maxvax Biotechnology \/ Henan Center for Disease Control and Prevention | Hunan Provincial Center for Disease Control and Prevention | Hubei Provincial Center for Disease Control and Prevention | Shaanxi Provincial Center for Disease Control and Prevention | Guangdong Center for"},{"orgOrder":0,"company":"Chengdu Maxvax Biotechnology","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"CHINA","productType":"Vaccine","year":"2025","type":"Inapplicable","leadProduct":"Recombinant Zoster Vaccine","moa":"Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Phase III","graph3":"Chengdu Maxvax Biotechnology","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Injection","sponsorNew":"Chengdu Maxvax Biotechnology \/ Undisclosed","highestDevelopmentStatusID":"10","companyTruncated":"Chengdu Maxvax Biotechnology \/ Undisclosed"}]

    Find Clinical Drug Pipeline Developments & Deals by Chengdu Maxvax Biotechnology

    Menu

    Chengdu Maxvax Biotechnology

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Chengdu Maxvax Biotechnology

                            China arrow
                            BIO Partnering at JPM
                            Not Confirmed

                            Chengdu Maxvax Biotechnology

                            China arrow
                            BIO Partnering at JPM
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Recombinant Zoster Vaccine

                            Therapeutic Area : Infections and Infectious Diseases

                            Study Phase : Phase III

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Long-term Efficacy of Recombinant Zoster Vaccine (CHO Cell) Study

                            Details : Recombinant Zoster Vaccine is a vaccine drug candidate, which is currently being evaluated in Phase III clinical studies for the treatment of Herpes Zoster.

                            Product Name : Undisclosed

                            Product Type : Vaccine

                            Upfront Cash : Inapplicable

                            December 18, 2025

                            Lead Product(s) : Recombinant Zoster Vaccine

                            Therapeutic Area : Infections and Infectious Diseases

                            Highest Development Status : Phase III

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Chengdu Maxvax Biotechnology

                            China arrow
                            BIO Partnering at JPM
                            Not Confirmed

                            Chengdu Maxvax Biotechnology

                            China arrow
                            BIO Partnering at JPM
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Recombinant Respiratory Syncytial Virus Vaccine

                            Therapeutic Area : Infections and Infectious Diseases

                            Study Phase : Phase III

                            Sponsor : Henan Center for Disease Control and Prevention | Hunan Provincial Center for Disease Control and Prevention | Hubei Provincial Center for Disease Control and Prevention | Shaanxi Provincial Center for Disease Control and Prevention | Guangdong Center for

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Phase III Clinical Trial of the Recombinant Respiratory Syncytial Virus Vaccine ( CHO Cell)

                            Details : Recombinant Respiratory Syncytial Virus Vaccine is a drug candidate, which is currently being evaluated in Phase III clinical studies for the treatment of Respiratory Syncytial Virus Infections.

                            Product Name : Undisclosed

                            Product Type : Vaccine

                            Upfront Cash : Inapplicable

                            December 09, 2025

                            Lead Product(s) : Recombinant Respiratory Syncytial Virus Vaccine

                            Therapeutic Area : Infections and Infectious Diseases

                            Highest Development Status : Phase III

                            Sponsor : Henan Center for Disease Control and Prevention | Hunan Provincial Center for Disease Control and Prevention | Hubei Provincial Center for Disease Control and Prevention | Shaanxi Provincial Center for Disease Control and Prevention | Guangdong Center for

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            • Privacy policy
                            • Terms and conditions
                            • Disclaimers
                            • LinkedIn
                            • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.